Arcus Biosciences' cancer drug candidate, quemliclustat, earns FDA orphan drug status, ensuring incentives and exclusivity.

Our large observational study adds long-term survival to the mounting data supporting the use and safety of conservative surgery for low-risk, early-stage cervical carcinoma,” the researchers wrote.

The FDA has approved a groundbreaking new therapy for patients battling late-stage melanoma, offering hope when options run out.

Determined to make HPV and cervical cancer screenings less invasive, these researchers have turned to menstrual blood.

Nephrotoxicity: Cisplatin, the main chemo drug used to treat cervical cancer, can damage the kidneys (also called nephrotoxicity). Many times the damage is preventable and reversible, but sometimes it ...

Electra D. Paskett, PhD, MSPH, FACE, FAACR, was elected as a fellow to the American Association for Cancer Research Academy ...

Finding cervical cancer often starts with an abnormal HPV (human papillomavirus) or Pap test result. This will lead to further tests which can diagnose cervical cancer or pre-cancer. The Pap test and ...

Researchers are one step closer to developing a simple, at-home test to prevent cervical cancer or treat it early, shows a study from University of Florida Health Cancer Center and Purdue University ...

Supports Advancement of GeoVax's Phase 2 Gedeptin ® Trial in Recurrent Head and Neck Cancer. ATLANTA, GA- June 24, 2025- GeoVax Labs, Inc., a clinical-stage biotechnology company developing multi ...

FDA expands AstraZeneca's Datroway label, making it the first TROP2-directed lung cancer therapy approved in the United States.